Stiles Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-41,898
Closed -$1.21M 176
2023
Q4
$1.21M Sell
41,898
-6,483
-13% -$196K 0.55% 63
2023
Q3
$1.6M Sell
48,381
-3,068
-6% -$108K 0.83% 37
2023
Q2
$1.89M Sell
51,449
-2,318
-4% -$90.2K 0.94% 28
2023
Q1
$2.19M Buy
53,767
+616
+1% +$26.6K 1.18% 21
2022
Q4
$2.72M Buy
53,151
+7,638
+17% +$366K 1.56% 17
2022
Q3
$1.99M Buy
45,513
+2,393
+6% +$116K 1.21% 21
2022
Q2
$2.26M Buy
43,120
+926
+2% +$47.2K 1.36% 19
2022
Q1
$2.18M Buy
42,194
+3,094
+8% +$161K 1.09% 23
2021
Q4
$2.31M Buy
+39,100
New +$1.94M 1.11% 26

Other funds holding PFE

Stiles Financial Services's PFE Position: Q1 2024 in Review

Stiles Financial Services sold out of Pfizer (PFE) in Q1 2024, closing a stake of 41,898 shares — an estimated $1.21M sold.

Stiles Financial Services first reported a position in PFE in Q4 2021 and held it in 9 quarters. The position peaked at $2.72M in Q4 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Stiles Financial Services reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Stiles Financial Services sold 41,898 Pfizer shares in Q1 2024, an estimated $1.21M.
  • Stiles Financial Services first reported a position in Pfizer in Q4 2021 and held it in 9 quarters.
  • Stiles Financial Services's Pfizer position peaked at $2.72M in Q4 2022.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Stiles Financial Services's 13F filing for Q1 2024, filed 30 Apr 2024.